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Intraneuronal accumulation of amyloid β (iAβ) has been linked to mild cognitive impairment
that may precede Alzheimer’s disease (AD) onset. This neuropathological trait was recently
mimicked in a novel animal model of AD, the hemizygous transgenic McGill-R-Thy1-APP
(Tg+/−) rat. The characterization of the behavioral phenotypes in this animal model could
provide a baseline of efficacy for earlier therapeutic interventions. The aim of the present
study was to undertake a longitudinal study of Aβ accumulation and a comprehensive
behavioral evaluation of this transgenic rat model. We assessed exploratory activity,
anxiety-related behaviors, recognition memory, working memory, spatial learning and
reference memory at 3, 6, and 12 months of age. In parallel, we measured Aβ by ELISA,
Western blots and semiquantitative immunohistochemistry in hippocampal samples.
SDS-soluble Aβ peptide accumulated at low levels (∼9 pg/mg) without differences among
ages. However, Western blots showed SDS-resistant Aβ oligomers (∼30 kDa) at 6 and
12 months, but not at 3 months. When compared to wild-type (WT), male Tg+/− rats
exhibited a spatial reference memory deficit in the Morris Water Maze (MWM) as early as
3 months of age, which persisted at 6 and 12 months. In addition, Tg+/− rats displayed
a working memory impairment in the Y-maze and higher anxiety levels in the Open Field
(OF) at 6 and 12 months of age, but not at 3 months. Exploratory activity in the OF was
similar to that of WT at all-time points. Spatial learning in the MWM and the recognition
memory, as assessed by the Novel Object Recognition Test, were unimpaired at any
time point. The data from the present study demonstrate that the hemizygous transgenic
McGill-R-Thy1-APP rat has a wide array of behavioral and cognitive impairments from
young adulthood to middle-age. The low Aβ burden and early emotional and cognitive
deficits in this transgenic rat model supports its potential use for drug discovery purposes
in early AD.
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INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative disorder that fre-
quently begins with memory complaints progressing to a severe
deterioration of multiple memory systems (Eustache et al., 2006).
In addition to cognitive impairment, AD patients exhibit sev-
eral neuropsychiatric symptoms with the progression of the dis-
ease (Geda et al., 2013). Some of the classical neuropathological
changes in AD are the presence of amyloid β (Aβ) deposits and
neurofibrillary tangles which initiate in the entorhinal cortex and
hippocampus, and spread to the medial temporal lobe (Scahill
et al., 2002). This progression of neuropathology leads to episodic
and semantic memory deficits that can be detected at early stages
of the disease (Bondi et al., 1999, 2008; Collie and Maruff, 2000;
Schmitt et al., 2000; Smith et al., 2007). As the disease pro-
gresses, other cognitive domains, such as attention and executive
function, among others, are affected (Bondi et al., 2008).
Recent reports suggest that intraneuronal accumulation of Aβ
(iAβ) takes place with the aging of the human brain many years
prior to Aβ plaques accumulation and Alzheimer’s disease onset
(Gouras et al., 2000; D’Andrea et al., 2001). Aging is the pre-
dominant risk factor for AD and there is biochemical evidence
supporting that the disease has an extensive preclinical phase
(Sperling et al., 2011; Bateman et al., 2012). In this context, pre-
ventive medicine combined with early diagnosis may allow a
substantial proportion of aged people to escape from suffering
AD. The relevance of the early stage of AD is further supported
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by the failure of recent clinical trials aimed at reducing extracellu-
lar Aβ levels and plaque formation (Laurijssens et al., 2013; Vellas
et al., 2013). Some of the reasons proposed for the failure may
be the initiation of the trials in demented patients with serious
brain damage together with unforeseen design flaws in the stud-
ies based on results from inadequate animal models (Laurijssens
et al., 2013; Vellas et al., 2013).
To test potential novel drug therapies specific for early stages
of AD it is necessary to develop an animal model at a pre-plaque
stage with a progressive decline in emotional and cognitive func-
tion. The phenotype should be sensitive to iAβ accumulation and
aging. Transgenic mouse models of AD have been widely used
to model the impairments in some cognitive domains shown
in patients with AD, such as semantic, working and recognition
memory (Webster et al., 2014). Semantic memory refers to a con-
scious recollection and retrieval of factual information and in
rodents is most closely correlated with reference memory. The lat-
ter implies the learning of certain aspects of a task that remain
constant throughout the behavioral test (Webster et al., 2014).
Working memory is a system that holds information for a lim-
ited amount of time, allowing its use and manipulation to guide
behaviors (Baddeley, 2003). Recognition memory belongs to the
long-term declarative memory system and consists in the abil-
ity to recognize individuals, events and objects that were already
encountered (Ally, 2012).
Available transgenic mice of AD have a general difficulty
in recreating the characteristics of early AD as most of them
show an aggressive neuropathological phenotype characterized
by a massive plaque formation (Do Carmo and Cuello, 2013).
Transgenesis in rats offers great potential to decipher subtle and
early aspects of AD pathology. The rat is, in many aspects, closer
to humans than mice. Because of its complex CNS and its pre-
dictable and multi-faceted behavioral display, this species is of
great value for accurate cognitive assessment (Whishaw et al.,
2001; Abbott, 2004). Different transgenic rat models of AD have
been developed in the last 10 years (Do Carmo and Cuello, 2013)
however, only two models, the UKUR25 (Echeverria et al., 2004)
and the hemizygous McGill-R-Thy1-APP (Leon et al., 2010)
show exclusively iAβ accumulation in cortex and hippocampus
without amyloid plaques or tangles at later stages. The differ-
ence between both models is that McGill-R-Thy1-APP rats show
progressive amyloid pathology from postnatal week one while
UKUR25 rats from 6 months of age (Echeverria et al., 2004; Leon
et al., 2010). In contrast to other transgenic rat models of AD,
such as UKUR25 and TgF344-AD in which iAβ accumulation is
sufficient to increase p-Tau levels, available bibliographic reports
do not indicate that McGill-R-Thy1-APP rat model develops Tau
pathology (Do Carmo and Cuello, 2013). This discrepancy can
be explained by differences in the genetic background and the
transgene expressed.
The McGill-R-Thy1-APP model was previously evaluated in
the Morris Water Maze (MWM) test (Leon et al., 2010). MWM
is the most widely employed spatial learning and memory task
systematically impaired in all of the different strains of AD trans-
genic mice (Webster et al., 2014). Recently, it was also reported
that the hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rat,
the least genetically aggressive AD transgenic model developed so
far, also showed impairments in auditory fear conditioning and
in the Novel Object Recognition and Location (NORL) task as
early as 3 months of age (Iulita et al., 2014). However, it was not
indicated if by this age Tg+/− rats accumulate soluble Aβ pep-
tides as compared to wild-type littermates (Iulita et al., 2014). In
addition, working memory and the temporal progression of AD-
like non-cognitive behavioral abnormalities, which are affected
early during the course of AD, were not determined in this novel
transgenic animal model.
Multiple behavioral tasks should ideally be used to character-
ize the phenotypes of potential animal models of AD since in
the clinical setting, a wide range of neuropsychological tests are
employed to determine the profile of the cognitive impairment
(Gainotti et al., 2014; Webster et al., 2014). In the present study,
by using a longitudinal assessment procedure, we sought to deter-
mine the levels and accumulation of soluble Aβ and iAβ peptides
and the development of impairments in the exploratory activity,
emotional behavior and working and spatial reference memory
in Tg+/− rats. In this way, we will test if this model recapitu-
lates some of the biochemical, emotional and cognitive alterations
seen in pre-symptomatic AD. Our results could be relevant to
define in this animal model the critical window for therapeutic
interventions that may be applied to early stages of AD.
MATERIALS AND METHODS
ETHICAL STATEMENTS
The study was carried out in strict accordance with the guide-
lines of the OLAW-NIH (Office Laboratory Animal Welfare). The
protocol was approved by the local Animal Care Committee of
Fundación Instituto Leloir (FIL) Assurance# A5168-01.
ANIMALS
Hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rats, har-
boring the human APP751 transgene with the Swedish and
Indiana mutation under the control of the murine Thy1.2 pro-
moter (Leon et al., 2010), were provided to Fundación Instituto
Leloir (FIL) by The Royal Institution for the Advancement of
Learning/McGill University, Montreal, Quebec (Canada).
HUSBANDRY AND GENOTYPING
An in-house breeding colony was established at FIL by cross-
breeding Tg+/− males with wild-type Wistar females rats. Each
litter was culled to 10 pups (up to 8 males per litter were left).
At weaning (21 post-natal days), dams were removed from the
litters and pups were genotyped as described below. When the
results of the genotyping were available (between 22 and 23
post-natal days), rats were pseudorandomly assigned to exper-
imental groups. To avoid the litter effect, groups were made
up of pups from 3 to 4 different litters. Animals were main-
tained on a 12-h light/12-h dark cycle, group-housed 2–4 per
cage and had ad libitum access to water and a standard rodent
diet. Tissue samples were obtained by ear punches from the
litters to determine the genotype of each rat. Genotyping was
performed using a validated protocol. Briefly, genomic DNA
was prepared from ear biopsy tissue using proteinase K diges-
tion, followed by phenol/chloroform/isoamyl alcohol extrac-
tion (Life Technologies). DNA quantification was determined
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in a Nanodrop 2000 spectrofotometer. Samples with a ratio
of absorbance at 260/280 and 260/230 nm above 1.80 were
used for PCR to recognize whether or not the rat carried
the human APP (hAPP) gene. The following sets of primers
were used: APP-F 5′-AGGACTGACCACTCGACCAG-3′; APP-R
5′-CGGGGGTCTAGTTCTGGAT-3′; CyclophilinG-F 5′- TACAA
CAGTAGAACAAGGGAGCGAAG-3′ and CyclophilinG-R 5′-
ATCCCTCCTTCTTCTCCTCCTATCTTT-3′. Cycling conditions
were: 95◦C (15min) and 40 cycles of 94◦C (30 s), 54◦C (1min),
72◦C (1min) followed by one step at 72◦C (2min) and kept at
4◦C until processed. PCR products were resolved by 2% agarose
mini-gel electrophoresis in TBE buffer and visualized with ethid-
ium bromide (10mg/ml) staining under UV light. Cyclophilin
G amplicon (248 bp) was used as a housekeeping gene to verify
DNA integrity and PCR conditions. The hAPP amplicon (387 bp)
indicates the presence of the human transgene. To verify the hem-
izygocity of the transgenic rats, quantitative PCR (qPCR) was per-
formed by using the same set of hAPP primers as described above
and the following set of GAPDH (used as housekeeping gene)
primers: GAPDH-F: 5′-GGGGAAGGACGCTGTACGGG-3′ and
GAPDH-R: 5′-AAGGGGAGC AACAGCTGGGGT-3′. A total of
1 ng of genomic DNA was used per well (5μl of a 0.2 ng/μl
dilution). Samples were plated in triplicate. SYBR-Green qPCR
was performed by using the KAPA SYBR® FAST Universal 2X
qPCR Master Mix (Kapa Biosystems). Reactions were run in a
Stratagene Mx3005P cycler and results analyzed by the MxPro
software in a Comparative Quantitation mode. In all of the runs a
genomic DNA sample of a hemizygous animal was included and
used as an internal calibrator. If the unknown sample is hemizy-
gous, the relative quantity (dRn) value should be between 0.8 and
1.3; if the unknown sample is homozygous the result is close to a
value of 2 (between 1.8 and 2.3).
EXPERIMENTAL DESIGN
For time-course analysis of the behavioral phenotype, 3 cohorts
of male rats consisting in Tg+/− and wild-type (WT) littermates
were used. Rats were divided in 6 experimental groups as follows:
group 1 (3 months old Tg+/− rats; n = 10); group 2 (3 months
old WT rats; n = 9); group 3 (6 months old Tg+/− rats; n = 9);
group 4 (6 months old WT rats; n = 7); group 5 (12 months old
Tg+/− rats; n = 11); group 6 (6months oldWT rats; n = 11) (see
Figure 2). Only male rats were used to avoid any potential effects
of changes in the female estrus cycle on behavioral performance.
HIPPOCAMPAL ISOLATION
Three groups (n = 3/group) of naïve Tg+/− male rats of 3, 6,
and 12 months of age, and one group (n = 3) of naïve WT
male rats of 12 months of age, were anesthetized with ketamine
(50mg/kg) and xylacine (10mg/kg), perfused transaortically with
0.9% sodium chloride with 200 U/l heparine and brains were
quickly removed as described previously (Leal et al., 2006). Brains
were divided into left and right hemispheres. Hippocampus was
isolated from left hemisphere and retained for biochemical stud-
ies. The right hemisphere was post-fixed in 4% paraformaldehyde
in 0.1M phosphate buffer (PB), pH 7.4 overnight at 4◦C, and
finally transferred to a solution of 30% sucrose in 0.1M PB for
5 days, or until sectioned for immunohystochemistry into 40μm
coronal sections with a freezing sledge microtome (SM 2000R,
Leica) at −20◦C. None of the animals assigned to immuno-
histochemical and biochemical experiments were submitted to
behavioral testing.
SDS-SOLUBLE Aβ PEPTIDE QUANTITATION
To estimate the levels of hippocampal SDS-soluble Aβ pep-
tides, 100mg of hippocampus were homogenized with a manual
Teflon glass homogenizer in 1ml of RIPA buffer (150mM NaCl,
0.5% sodium deoxycolate, 1% Triton X-100, 2% SDS) containing
proteases inhibitors (5mM EDTA, 5mM EGTA, 5μg/ml leu-
peptin, 10μg/ml aprotinin, 1μg/ml pepstatin) and phosphatases
inhibitors (50mM sodium fluoride and 5mM sodium ortho-
vanadate) and centrifuged at 20,000 × g at 4◦C for 45min using
a Eppendorf microcentrifuge. Supernatants were aliquoted and
stored at −80◦C. Individual samples were analyzed to assess
SDS-soluble human Aβ40 or Aβ42 levels by using sandwich
ELISA tests commercially available (Invitrogen). Results were
expressed as pg of Aβ/mg of hippocampal homogenate pro-
teins as determined with a bicinchoninic acid assay (Pierce,
Rockford, IL) and were corrected by the signal of WT protein
background. Determinations were performed in duplicate sam-
ples in three independent experiments. To evaluate SDS-resistant
oligomeric Aβ levels, samples (250μg/lane) were run in SDS-
Tricine 12% gels and processed as previously described (Leon
et al., 2010). Immunoreactivity was detected by Western blot
using an enhanced chemiluminescence detection system (ECL,
Thermo Scientific) and membranes analyzed and quantitated
with a STORM 840 Phosphor Imager (GE Healthcare). Group
values were obtained simultaneously and normalized with respect
to APP immunoreactivity.
ESTIMATION OF THE VOLUME FRACTION OF THE HIPPOCAMPUS
AFFECTED BY iAβ DEPOSITION
Brain sections were analyzed by using systematic random sam-
pling. Every sixth brain section (240μm apart) was stained using
a free-floating immunohistochemistry procedure as previously
described (Leon et al., 2010). iAβ label was detected with McSA1
(1:4000) mouse monoclonal antibody and sections were analyzed
at 40× magnification by using an Olympus BX50 microscope.
Immunoreactivity was assessed with Image J software (NIH,
USA) in sections between the coordinates −2.30 and −3.8mm
from bregma for dorsal hippocampus and between −4.16
and −6.04mm from bregma for ventral hippocampus (Paxinos
and Watson, 2009) following a standard protocol. Stereological
estimation of the hippocampal volume affected by iAβ is
described below in Image analysis Section.
NEUROLOGICAL SCREENING AND BEHAVIORAL TESTING
One week before starting with the behavioral battery each cohort
was transported to ININCA (School of Medicine, Universidad
de Buenos Aires) where a behavioral core facility is available.
Throughout the study period, animals were housed in a con-
trolled environment (21 ± 2◦C, 50–60% relative humidity, 12 h
light/12 h dark schedule) and all efforts were made to min-
imize discomfort. After acclimation, rats were handled daily
(5min/day) for three consecutive days and subjected to a basic
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neurological examination which consisted of a battery of neu-
rological reflex tests: righting response after being placed on the
dorsal side; eye blink (response to light touch with a small camel
hair brush), ear twitch, and limb withdrawal in response to tac-
tile stimuli (light touch with a gloved finger); orienting response
to a visual stimuli (flashlight) and startle response following an
auditory stimulus (a metal clicker) as previously reported (Cohen
et al., 2013). Responses were scored as being present or absent.
The maximum time period in which behavioral tests were car-
ried out was between 8:00 a.m. and 5 p.m. Since there is a major
circadian influence on EPM and OF performance (Verma et al.,
2010), these tests were conducted between 8:00 a.m. and 12:00
p.m. Moreover, testing order of the groups was counterbalanced
to avoid the confounding effect of time of the day at which ani-
mals were tested. The order of tests were as follows: Elevated Plus
Maze (EPM) test, Open Field (OF) test, Novel Object Recognition
Test (NORT), Y-maze spontaneous alternation (Y-Maze) test, and
Morris Water Maze (MWM) test. The interval between tests was
at least 24 h. After each animal was tested, the entire appara-
tus and objects in the NORT were cleaned with 70% ethanol
to prevent a bias due to olfactory cues. All testing sessions were
digitally recorded (JVC Everio GZ-HD620) and analyzed using
a computerized video-tracking system (Ethovision XT, version 7,
Noldus Information Technology, Wageningen, The Netherlands)
or the ethological observation software JWatcher V1.0. All the
experimenters were blinded to the genotype of the animals.
Elevated plus maze test
The EPM test assesses anxiety-like behaviors (Pellow et al., 1985).
The apparatus consisted of a black melamine central square plat-
form (11 × 11 cm) from which four black melamine arms radiate
(50 × 11 cm) separated from each other by 90◦. Two of the arms
(“closed arms”) have a wall (40 cm in height) all around its
perimeter but not in the entrance and the other two arms (“open
arms”) do not have any wall but with raised edges (0.25 cm)
around its perimeter. The maze was elevated one meter from the
floor by five legs. Light intensity in the open arms was 80–90 lux.
Each rat was placed onto the central platform facing an open
arm and allowed to freely explore the maze for 5min. An arm
entry was counted when rat introduced its four paws into an arm.
The following dependent variables were recorded: total distance
moved, number of closed arm entries, percentage of open arm
entries
(
N◦ open arm entries
Total entries × 100
)
and percentage of time spent
in open arms
(
Time spent in open arms




The OF test was used to assess spontaneous exploratory activity
and anxiety-related behaviors (Walsh and Cummins, 1976). The
apparatus consisted of a blackmelamine square (60 × 60 cm) sur-
rounded by walls of 40 cm in height. A central area was arbitrarily
defined as a square of 30 × 30 cm and it was drawn over the image
of the OF in the video-tracking system. A rat was considered to be
into the central area when its four paws were on it. Light inten-
sity in the center of the OF was 70–80 lux. Each rat was placed in
the center of the maze and its behavior was analyzed for 5min.
The following dependent variables were recorded: total distance
moved, number of rears, number of entries into the central area
and time spent in central area.
Novel object recognition test
The NORT evaluates recognition memory of one previously
explored object (familiar) compared with one novel object (non-
familiar) (Ennaceur and Delacour, 1988; Ennaceur, 2010). NORT
was performed in the same OF apparatus 24 h after the OF test.
Rats were tested during two trials (sample and retention trials)
separated by an interval of 1 h during which they were returned
to their cages. In the sample trial (duration: 5min), each rat was
faced with two identical objects (called familiar objects) placed
in a symmetrical position and the time exploring freely each
object was recorded. In the retention trial (duration: 3min), one
of the two familiar objects was replaced by a novel object and
the time exploring each was recorded. Sets composed of three
copies of the same object were used to prevent odor cues and all
combinations and location of objects were used to prevent bias
due to preference for a particular object or location. Exploration
time was computed when the snout pointed to the object at a
distance ≤2 cm. Discrimination index (d1) and discrimination
ratio (d2) scores were calculated using the following formulas:
d1 = tn − tf and d2 = tn − tftn + tf , where tn = the amount of time
rats explored the novel object and tf = the amount of time rats
explored the familiar object.
Y-maze spontaneous alternation test
The Y-maze test was used to measure spatial working mem-
ory as previously described with minor modifications (Sierksma
et al., 2014). The apparatus consisted of three identical arms
(45 × 12 × 35 cm) diverging at 120◦ angle one to the other and an
equilateral triangular central area. Each animal was placed in the
center of the Y-maze and was free to explore the arena for 8min.
Rats tend to explore the least recently visited arm, and thus tend to
alternate visits between the three arms. For efficient alternation,
rats need to use working memory, and thus, they should maintain
an ongoing record of most recently visited arms, and continu-
ously update such record (Wietrzych et al., 2005). An arm entry
was scored when rat placed the four paws within that arm. The
following dependent variables were registered: total number of
arm entries, number of triads (sequence of three consecutive visits
to different arms), and percentage of alternation. An alternation
was defined as an entry into three different arms on consecu-
tive choices. The percentage of alternation was calculated as the
ratio of actual to maximum number of alternations. The max-
imum number of possible alternations was defined as the total
number of arm entries minus 2. A low percentage of alternation
is indicative of an impaired spatial working memory because the
rat cannot remember which arm it has just visited, and thus shows
decreased spontaneous alternation.
Morris water maze test
The apparatus used was previously described in detail by Galeano
et al. (2011). Briefly, it consisted of a circular galvanized steel pool
(180 cm in diameter and 60 cm in height), painted black, filled
with water at 22 ± 1◦C to a depth of 36–40 cm, and imaginarily
divided into four quadrants: North (N), East (E), South (S), and
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West (W). A cylindrical platform (10 cm in diameter and made of
transparent acrylic plastic) was placed 2 cm above (visible escape
platform) or beneath the water surface (hidden escape platform)
in the center of one of the quadrants. To enhance the visibility
of the platform during the cued learning training, a “flag” was
attached to the platform. The pool was located in the center of
an experimental room with multiple extra-maze visual geomet-
ric cues hanging on the wall. Indirect illumination was provided
by four spiral compact fluorescent lamp in each corner facing the
walls. The following dependent variables were recorded: latency
to the platform, distance swum to the platform, swimming speed,
time spent in each quadrant, the number of crossings over an
annulus zone of 20 cm in diameter (defined as a zone surround-
ing the location where the platform was located during the spatial
learning training), and time spent in the outer ring of the pool
(25 cm wide).
Cued learning. During cued learning the platform protruded
2 cm above water surface and a “flag” was attached to it (visible
escape platform). The maze was surrounded by black curtains to
minimize the availability of extra-maze cues. For each of the four
trials conducted on each day, the platform was moved to a dif-
ferent quadrant and a different start location was used. If a rat
had not located the platform before 120 s elapsed, it was gently
guided to the platform location and was allowed to remain there
for 15 s. Inter-trial interval duration was 20–30min. Two days of
cued training were conducted.
Spatial learning and reference memory. We used procedures
described previously with some modifications (Vorhees and
Williams, 2006; Galeano et al., 2011). Black curtains were
removed and the spatial learning phase of the task was performed
over five consecutive days with four trials per day. In each ses-
sion, rats were released into the pool from one of the four starting
positions (one per each quadrant) and the order of the sequence
was changed pseudorandomly between days. Animals were able
to escape from the water using the hidden escape platform that
was kept in the same location throughout the five spatial learning
sessions. A trial was finished when the animal found the escape
platform or when 120 s had elapsed, whichever occurred first. If
a rat failed to find the platform, the experimenter guided to it
by hand. Rats remained on the platform for 15 s with an inter-
trial interval of 20–30min. Twenty four hour after the last trial of
the learning phase, spatial reference memory was assessed with a
probe trial in which the escape platform was removed from the
pool and rats were released from a new starting position not used
during the learning phase. Time spent in each quadrant, the num-
ber of annulus crossings and the time spent in the outer ring of the
pool (thigmotactic swimming) was recorded. After each trial rats
were dried and when the session finished they were returned to
their colony room.
IMAGE ANALYSIS
For stereological estimations the contours of ventral and dorsal
hippocampus showing immunoreactivity for iAβ was drawn in
each section with Image J software (NIH, USA) tool to deter-
mine the affected area. The Cavalieri’s principle (Gundersen
and Jensen, 1987) was used to calculate the affected volume by
using the following formula: V = ∑AxNxE, where V = volume
(mm3);
∑
A = sum of area counted (mm2); N = number of
sections analyzed; E = thickness of each section (mm).
STATISTICAL ANALYSIS
All data are shown as the mean ± s.e.m. Data were analyzed by
Two-Way ANOVA or by Two-Way mixed ANOVA tests followed
by Tukey’s HSD post-hoc tests for multiple comparisons, unless
noted otherwise. The significance level was set at 5%. SPSS 15.0
for Windows software (Chicago, IL, USA) was used to perform all
statistical analyses.
RESULTS
PROGRESSION OF SOLUBLE Aβ AND iAβ ACCUMULATION IN Tg+/−
RATS
In order to better characterize Aβ-mediated neuropathology
at early age, we quantified the levels of SDS-soluble and
SDS-resistant peptide Aβ immunoreactivity in hippocampal
homogenates from 3, 6, and 12 months old animals by a com-
mercially available ELISA test and Western blotting, respectively.
By ELISA, we detected the presence of SDS-soluble human Aβ40
in Tg+/− hippocampal homogenates early at the age of 3 months
(9.16 ± 1.42 pg/mg). The levels of SDS-soluble human Aβ40,
however, did not differ significantly between Tg+/− rats at 6
months (9.84 ± 1.30 pg/mg) or 12 months (8.00 ± 3.19 pg/mg)
of age (F < 1), with an average of 9.00 ± 1.92 pg of Aβ40/mg
of total hippocampal proteins. By contrast, we were not able to
detect SDS-soluble human Aβ42 peptide in RIPA homogenates
of Tg+/− rats at any age analyzed. In addition, SDS-resistant Aβ
oligomers appeared in hippocampal homogenates of 6 and 12
months old Tg+/− rats, but not in 3 months old Tg+/− rats
(see Figure 1A). In accordance with previous reports, our data
show that in Tg+/− rats the neuropathology was restricted to iAβ
(see Figure 1B, upper panel) and no significant differences were
obtained in the volume fraction affected in dorsal or ventral hip-
pocampus among different ages analyzed (F < 1 for both areas
analyzed; see Figure 1B, lower panel). Our data strongly sug-
gest a subtle phenotype in Tg+/− rats with an “age-independent”
accumulation for SDS-soluble monomeric Aβ40 and iAβ but an
“age-dependent” accumulation for SDS-resistant Aβ oligomers.
GENERAL HEALTH AND NEUROLOGICAL SCREENING
Gross inspection of each rat prior to the behavioral experiments
did not reveal any visible differences betweenWT and Tg+/− ani-
mals. All animals appeared healthy and neurological reflexes were
all scored as being present.
ELEVATED PLUS MAZE TEST
Two-Way ANOVA tests revealed significant main effects of age
for “total distance moved” and “number of closed arm entries”
[F(2, 51) = 8.36, p = 0.001; F(2, 51) = 9.29, p < 0.001, respec-
tively]. By contrast, neither the main effects of genotype nor the
age × genotype interactions were significant (F < 1 for all cases).
These results suggest that locomotor activity changed with age,
regardless of the genotype. Post-hoc analysis confirmed that both
6- and 12-month-oldWT and Tg+/− rats moved less distance and
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FIGURE 1 | SDS-resistant Aβ oligomers and intracellular Aβ (iAβ)
accumulation in Tg+/− rats. (A) Representative Western blotting showing
APP expression and Aβ oligomers by using 6E10 monoclonal antibody.
Hippocampal samples of 6 and 12-month-old Tg+/− rats contained Aβ
oligomers (∼30 kDa) in contrast to 3-month-old Tg+/− or 12-month-old
wild-type (WT) littermates. (B) iAβ is present in the hippocampus and cortex
(Cx) of Tg+/− animals at 3, 6, and 12 months of age (upper panels). Scale
bar, 300μm. Inset, magnification of CA1 region decorated with iAβ (arrows)
in the neurons of granular layer. Scale bar, 30μm. Hippocampal volume
affected with iAβ is similar among different ages analyzed (lower panel).
Three groups (n = 3/group) of naïve Tg+/− male rats of 3, 6, and 12 months
of age, and one group (n = 3) of naïve WT male rats of 12 months of age
were assessed. These animals were not submitted to behavioral testing.
had a lower number of entries into closed arms than 3-month-
old groups (p < 0.05 for all comparisons; see Figures 3A,B).
Regarding “percentage of open arm entries” and “percentage of
time spent in open arms,” neither the main effects of age nor the
main effects of genotype nor the age× genotype interactions were
significant (F < 1 for all cases; see Figures 3C,D), indicating that
levels of anxiety were similar among all experimental groups.
FIGURE 2 | Experimental design, cohorts’ characteristics and
behavioral tests employed. Three cohorts (1, 2, and 3) of 3, 6, and 12
months old hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rats and
their wild-type (WT) littermates were assessed in a behavioral test battery
including: Elevated Plus Maze (EPM) test, Open Field (OF) test, Novel
Object Recognition Test (NORT), spontaneous alternation in the Y-maze test
(Y-maze), and cued and spatial reference memory versions of the Morris
Water Maze (MWM) test. Prior to behavioral assessment, a neurological
screening (N.S.) was performed and animals were euthanized after
completion of behavioral testing.
OPEN FIELD TEST
When “total distance moved” and “number of rears” were ana-
lyzed by Two-Way ANOVA tests, the main effects of age were sig-
nificant [F(2, 51) = 13.98, p < 0.001; F(2, 51) = 11.10, p < 0.001,
respectively] but neither the main effects of genotype nor the
age × genotype interactions were significant (F ≤ 1 for all cases).
Post-hoc multiple comparisons confirmed that locomotor and
rearing activity declined with age, since 6- and 12-month-oldWT
and Tg+/− rats moved less distance and presented a lower rearing
frequency than 3-month-old groups (p < 0.05 for all compar-
isons; see Figures 4A,B). Relative to anxiety levels, the Two-Way
ANOVA tests for “number of entries into the center” and “time
spent in central area” indicated that neither the main effects of
age nor the age × genotype interactions were significant (F ≤ 1
for all cases). However, the main effects of genotype showed sig-
nificant differences [F(2, 51) = 8.46, p = 0.005; F(2, 51) = 13.87,
p < 0.001, respectively]. Post-hoc analyses revealed that 6- and
12-month-old Tg+/− rats showed a lower number of entries and
spent less time in the center of the OF than WT groups (p < 0.05
for all comparisons; see Figures 4C,D). In contrast, 3-month-old
Tg+/− rats did not differ from their WT littermates in none of
the variables analyzed (see Figures 4C,D). Since the interactions
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FIGURE 3 | Locomotor activity and anxiety-related behaviors of
hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rats and wild-type
(WT) littermates in the Elevated Plus Maze (EPM) test. (A) Total distance
moved. (B) Number of closed arm entries. (C) Percentage of open arm
entries. (D) Percentage of time spent in open arms. Locomotor activity
declined with age, regardless of the genotype (A,B). No differences in
anxiety-related behaviors were observed between Tg+/− and WT rats at any
age (C,D). The number of animals tested was as follows: 9 WT and 10 Tg+/−
at 3 months, 7 WT and 9 Tg+/− at 6 months, and 11 WT and 11 Tg+/− at 12
months. Values are shown as the mean + s.e.m. ∗p ≤ 0.05.
age × genotype did not reach statistical significance, the lack of
differences between 3 month-old WT and Tg+/− groups should
be taken with caution (Tybout et al., 2001).
NOVEL OBJECT RECOGNITION TEST
The discrimination index (d1) and discrimination ratio (d2)
were not statistically different between genotypes or ages [Two-
Way ANOVA tests. d1. Genotype: F(1, 51) = 2.25, p = n.s.;
Age: F(2, 51) < 1; Genotype × age: F(2, 51) < 1. d2. Genotype:
F(1, 51) < 1; Age: F(2, 51) = 1.25, p = n.s.; Genotype × age:
F(2, 51) < 1]. One sample t-tests indicated that d1 and d2 scores
were significantly different from those expected by chance for all
experimental groups (p < 0.05 for all cases; see Figures 5A,B).
These results demonstrate that WT and Tg+/− rats were able to
recognize the novel object from the familiar one at all ages tested.
Y-MAZE TEST
A significant main effect of age for “total number of arm entries”
[F(2, 51) = 17.52, p < 0.001] was revealed by a Two-Way ANOVA
test. Neither the main effect of genotype nor the age × genotype
interaction were significant (F < 1 for both cases). Regardless
of the genotype, post-hoc analysis showed that 12-month-old
WT and Tg+/− rats displayed a lower number of arm entries
than 3- and 6-month-old groups (p < 0.01 for all comparisons;
see Figure 6A). When the “percentage of alternation” was also
analyzed by a Two-Way ANOVA test, the main effects of age
and genotype and the interaction were all significant [F(2, 51) =
4.48, p = 0.016; F(2, 51) = 7.81, p = 0.007; F(2, 51) = 3.13, p =
0.05, respectively]. Post-hoc tests indicated that 6- and 12-month-
old Tg+/− rats showed a lower percentage of alternation than
their WT littermates (p = 0.020 and p = 0.006, respectively; see
Figure 6B), while 3-month-old groups displayed similar levels
of alternation (see Figure 6B). These results indicate that Tg+/−
rats displayed a spontaneous alternation impairment at 6 and 12
months of age.
MORRIS WATER MAZE TEST
Cued learning
At the three ages studied, post-hoc multiple comparisons showed
that, during the second day, both genotypes significantly reduced
their latency to reach the visible platform to similar levels (p <
0.01 for all cases; see Figures 7A–C) [Two-Way mixed ANOVA
test. 3 months old. Day: F(1, 17) = 66.57, p < 0.001; Genotype:
F(1, 17) < 1; Day × genotype: F(1, 17) < 1. 6 months old. Day:
F(1, 14) = 145.87, p < 0.001; Genotype: F(1, 14) = 1.44, p = n.s.;
Day × genotype: F(1, 14) < 1. 12 months old. Day: F(1, 20) =
400.14, p < 0.001; Genotype: F(1, 20) < 1; Day × genotype:
F(1, 20) = 8.27, p < 0.01]. These results suggest that transgenic
groups were not visually impaired and showed no deficit in
swimming ability.
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FIGURE 4 | Locomotor activity, exploration and anxiety-related
behaviors of hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rats
and wild-type (WT) littermates in the Open Field (OF) test. (A) Total
distance moved. (B) Number of rears. (C) Entries into the center. (D)
Time spent in the central area. Regardless of the genotype, 6 and 12
months old rats showed less locomotion and rearing activity than 3
months old rats (A,B). Tg+/− rats of 6 and 12 months of age showed
increased anxiety with a lower number of entries into center (C) and
less time spent in the central area (D) than WT littermates. The number
of animals tested was as follows: 9 WT and 10 Tg+/− at 3 months, 7
WT and 9 Tg+/− at 6 months, and 11 WT and 11 Tg+/− at 12 months.
Values are shown as the mean + s.e.m. ∗p ≤ 0.05; ∗∗p ≤ 0.01.
Spatial learning
Two-Way mixed ANOVA tests, with day as within-subject fac-
tor and genotype as between-subject factor, indicated that 3, 6,
and 12 months old rats significantly decreased their escape laten-
cies and distances swum to reach the hidden platform across
days, regardless of the genotype [Escape Latency. 3 months
old. Day: F(4, 68) = 40.36, p < 0.001; Genotype: F(1, 17) < 1;
Day × genotype: F(4, 68) = 1.6, p = n.s. 6 months old. Day:
F(4, 56) = 20.42, p < 0.001; Genotype: F(1, 14) < 1; Day × geno-
type: F(4, 56) < 1. 12 months old. Day: F(4, 80) = 61.36, p <
0.001; Genotype: F(1, 20) < 1; Day × genotype: F(4, 80) < 1.
Distance swum. 3 months old. Day: F(4, 68) = 48.24, p < 0.001;
Genotype: F(1, 17) < 1; Day × genotype: F(4, 68) < 1. 6 months
old. Day: F(4, 56) = 21.14, p < 0.001; Genotype: F(1, 14) < 1;
Day × genotype: F(4, 56) < 1. 12 months old. Day: F(4, 80) =
50.67, p < 0.001; Genotype: F(1, 20) < 1; Day × genotype:
F(4, 80) < 1]. Post-hoc analyses confirmed that, at any age,
escape latencies and distances swum did not differ between
WT and Tg+/− groups on any day of the learning phase
(p = n.s. for all comparisons), indicating that all experimen-
tal groups were able to learn the task at an equivalent rate
(see Figures 8A–F). Moreover, both genotypes displayed simi-
lar swimming speeds at all ages (see Figure 1 in Supplementary
Material), suggesting similar levels of motivation to solve
the task.
Spatial reference memory
Two-Way mixed ANOVA tests, with quadrant as within-subject
factor and genotype as between-subject factor, were performed
to analyze the amount of time that experimental groups spent
in each one of the quadrant of the MWM when platform was
removed. At the three ages analyzed, results showed that the
main effects of quadrant and the quadrant × genotype interac-
tions were significant, in contrast to the main effects of genotype
[3 months old. Quadrant: F(3, 51) = 5.49, p = 0.02; Genotype:
F(1, 17) < 1; Quadrant x genotype: F(3, 51) = 2.73, p = 0.04.
6 months old. Quadrant: F(3, 42) = 3.74, p = 0.02; Genotype:
F(1, 14) < 1; Quadrant × genotype: F(3, 42) = 2.70, p = 0.05.
12 months old. Quadrant: F(3, 60) = 2.87, p = 0.04; Genotype:
F(1, 20) < 1; Quadrant × genotype: F(3, 60) = 2.74, p = 0.04].
Post-hoc tests revealed that 3, 6, and 12 months old WT rats spent
significantly more time in the quadrant where the platform was
located (target quadrant) than in the remaining quadrants (p <
0.05 for all comparisons; see Figures 9A,C,E). On the contrary,
Tg+/− rats spent similar amount of time in each one of the quad-
rant at any age (p = n.s. for all comparisons; see Figures 9A,C,E).
Furthermore, Student’s t-tests revealed that 3 and 12 months old
WT rats crossed the annulus zone significantly more time than
Tg+/− rats (p < 0.05 for both cases; see Figures 9B,F). A strong
tendency was also detected for the 6 months old WT group (see
Figure 9D). Overall, these results indicate that Tg+/− rats had a
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FIGURE 5 | Performance of hemizygous transgenic McGill-R-Thy1-APP
(Tg+/−) rats and wild-type (WT) littermates in the Novel Object
Recognition Test (NORT). (A) Discrimination index (d1). (B) Discrimination
ratio (d2). At all the ages tested, both genotypes recognized the novel
object. The dashed lines indicate an equivalent exploration time for the two
objects (chance level). The number of animals tested was as follows: 9 WT
and 10 Tg+/− at 3 months, 7 WT and 9 Tg+/− at 6 months, and 11 WT and
11 Tg+/− at 12 months. Values are shown as the mean + s.e.m. ∗p ≤ 0.05;
∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001 vs. chance (dashed lines).
significant impairment to remember the location of the platform
as compared to WT animals. Regarding swimming speed and
thigmotactic swimming, no differences were detected in probe
trials (see Figures 1, 2 in Supplementary Material).
DISCUSSION
Hemizygous McGill-R-Thy1-APP transgenic rats represent an
interesting model of early AD pathology as the presence of Aβ
is limited to the intracellular compartment. While the longitu-
dinal accumulation of Aβ in its homozygous counterpart has
been recently documented (Iulita et al., 2014), little is known
regarding the progression of the Aβ intracellular accumulation
in the heterozygous counterpart and of the behavioral outcomes.
In order to address this issue, we investigated the occurrence of
human Aβ40 peptides after 2% SDS solubilization in hippocam-
pal homogenates from 3-, 6-, and 12-month-old Tg+/− rats by
using an ELISA specific for human Aβ peptide. We were able
to detect accumulation of Aβ40 immunoreactive material which
remained at similar levels from 3 to 12months of age. This finding
is in agreement with the data reported in homozygous McGill-
R-Thy1-APP rats (Iulita et al., 2014). The impossibility to detect
Aβ42 peptide may be explained by the low amount of this pep-
tide in the 2% SDS homogenates and the dynamic range of the
FIGURE 6 | Spontaneous alternation in the Y-maze test. (A) Total
number of arm entries. (B) Percentage of alternation. Regardless of the
genotype, 12 months old rats showed less total number of arm entries than
3 and 6 months old rats (A). At 6 and 12 months of age, hemizygous
transgenic McGill-R-Thy1-APP (Tg+/−) rats exhibited an impairment in
spontaneous alternation compared with wild-type (WT) groups (B). The
number of animals tested was as follows: 9 WT and 10 Tg+/− at 3 months,
7 WT and 9 Tg+/− at 6 months, and 11 WT and 11 Tg+/− at 12 months.
Values are shown as the mean + s.e.m. ∗p ≤ 0.05; ∗∗p ≤ 0.01.
ELISA test used in this experiment (between 1.56 and 100 pg/ml).
Yet, the presence of SDS-resistant Aβ oligomers was detected by
Western blot in 6- and 12-month-old animals. Since an amino-
terminal anti-Aβwas used it was not possible to determine if these
oligomers were composed of Aβ40, Aβ42 or both. To complement
the structural and neurochemical characterization, we performed
a longitudinal behavioral analysis of male hemizygous transgenic
McGill-R-Thy1-APP (Tg+/−) rats, in tightly controlled condi-
tions. To avoid high variability already reported in Tg+/− groups
(Leon et al., 2010) we followed 2 strategies: (1) exclusion of
females rats, which are known to introduce confounding factors
in behavioral tests (Mehta et al., 2013) and (2) the evaluation of at
least 9 animals in each Tg+/− group to increase statistical power.
As it was mentioned in the “Materials and Methods” Section, the
groups of animals that underwent the behavioral assessment were
not the same used to study Aβ accumulation.
EMOTIONAL BEHAVIOR
There are several reports on murine models of AD, aimed at
understanding the impact of amyloid formation on learning and
memory but few are focused on emotional behavior. In this
study, we analyzed the effect of genetic modification of APP on
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FIGURE 7 | Hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rats
showed an unimpaired cued learning in the Morris Water Maze (MWM)
test. Escape latency of wild-type (WT) and Tg+/− groups at 3 (A), 6 (B) and
12 (C) months of age. At all ages tested, both genotypes reduced their
escape latencies to similar levels from day 1 to day 2. The number of animals
tested was as follows: 9 WT and 10 Tg+/− at 3 months, 7 WT and 9 Tg+/− at
6 months, and 11 WT and 11 Tg+/− at 12 months. Values are shown as the
mean ± s.e.m. ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001 vs. day 1.
EPM and OF tests in Tg+/− rats in view of the tendency of AD
patients to be either apathetic or agitated (Chung and Cummings,
2000; Senanarong et al., 2004). We were unable to detect differ-
ences in anxiety-related behaviors between Tg+/− and WT rats
in the EPM test in the present study. Unchanged anxiety lev-
els assessed by EPM were described in transgenic mice lacking
amyloid plaques (Moran et al., 1995; Lalonde et al., 2002; Lee
et al., 2004; Boon et al., 2010) and in two models with Aβ plaques
(Arendash et al., 2001; Le Cudennec et al., 2008; Blanchard et al.,
2009). It is important to note that behavior in EPM was not
assessed in any of the transgenic rat models of AD described so
far (Do Carmo and Cuello, 2013) and that our results in Tg+/−
rats, lacking extracellular Aβ deposition even at late stages, are
in agreement with the concept that changes of EPM behavior
appear only in transgenic models of AD with an extensive neu-
ropathological phenotype (Savonenko et al., 2003; Lee et al., 2006;
Lalonde et al., 2012). It is important to note that the levels of
exploration of open arms seem to be low as compared to other
reports (see Figures 3C,D). This effect could be attributable to
the levels of illumination used (80–90 lux in the open arms). To
rule out the possibility of a floor effect that could be masking an
anxiety phenotype in Tg+/− rats in the EPM, future studies are
needed to investigate the behavior of these animals in this test
under different experimental conditions.
Only one transgenic rat model of AD (the Tg6590) has been
previously characterized for its performance in the OF. This trans-
genic rat model showed increased Aβ precursor protein (APP),
cerebrovascular deposits, few diffuse plaques and increased phos-
phorylated tau at 15months of age. At 9months old these animals
showed no differences either in the number of entries into center
or in the time spent in the central area of the OF, as compared
to control group (Kloskowska et al., 2010). By contrast, here we
show that Tg+/− rats are more anxious in the OF test at 6 months
of age. This behavior was also observed at 12 months of age, sug-
gesting the robustness of this phenotype. It is worth noting that
this anxious phenotype was observed in the OF test but not in the
EPM test. Previously, it was reported that the OF and the EPM
operationalize different aspects of emotional behavioral (Trullas
and Skolnick, 1993; Ramos et al., 1998). This lack of inter-test
correlations has been attributed to the multidimensional nature
of emotional behavior (Ramos, 2008). Therefore, it could be pos-
sible that the higher anxiety levels detected in Tg+/− rats in the
present study, reflect an specific dimension of emotional behavior
linked to OF activity. Finally, it is important to note that both tests
(EPM and OF) were sensitive to the age-related decline in spon-
taneous locomotor activity and exploration (see Figures 3A,B,
4A,B).
In summary, even if the emergency (Holmes, 2001) or the
light/dark box (Pinton et al., 2011) tests were not assessed in
this study, our report is the first analysis of the anxiety distur-
bances in a transgenic rat model of early AD that does not develop
Aβ plaques. It is of interest that the anxiety pattern described
here for the Tg+/− rats appear to closely mimic neuropsychiatric
symptoms described in some pre-clinical AD patients.
COGNITIVE BEHAVIOR
Ideally, genetically modified animal models of AD not only have
to replicate some of the hallmark neuropathology, such as plaque-
like amyloid accumulations and tau deposition, but also should
reproduce some of the cognitive impairments relevant to the
disease. In this context, near all of the transgenic mice models
with excessive Aβ either via transgenic overexpression of mutant
hAPP and/or its processing enzymes, typically present static cog-
nitive deficits that are evident early in life and progressive deficits
that are age-related and associated with increased concentra-
tions of deposited or unbound assemblies of Aβ (Kobayashi and
Chen, 2005). By contrast to transgenic mice in which a wide
battery of cognitive tests were performed, a narrower battery of
tests were used in transgenic rat models of AD. These included
MWM, Fear Conditioning, and Novel Object Recognition and
Location (NORL) test (Leon et al., 2010; Iulita et al., 2014).
Early description of the cognitive performance of hemizygous
transgenic McGill-R-Thy1-APP rat in the MWM showed that
at 3 months of age (n = 4) the learning curve was undistin-
guishable from that of WT (n = 8) rats while at 13 months of
age, Tg+/− rats (n = 4) exhibited a mild spatial learning deficit
reflected by a significantly increased escape latency, compared
to WT (n = 12), during the third day of the learning phase.
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FIGURE 8 | Spatial learning of hemizygous transgenic
McGill-R-Thy1-APP (Tg+/−) rats and wild-type (WT) littermates in the
Morris Water Maze (MWM) test. Escape latency and path length of Tg +/−
and WT rats at 3 (A,B), 6 (C,D) and 12 (E,F) months of age. At all ages
tested, both genotypes reduced their escape latencies and paths length at an
equivalent rate across days. The number of animals tested was as follows: 9
WT and 10 Tg+/− at 3 months, 7 WT and 9 Tg+/− at 6 months, and 11 WT
and 11 Tg+/− at 12 months. Values are shown as the mean ± s.e.m.
Moreover, spatial reference memory, assessed during the probe
trial, was not impaired at both ages, although a trend could be
seen in the 3 month-old group (Leon et al., 2010). To further
characterize the cognitive abilities of Tg+/− rats, in this study we
analyzed the performance of these animals in three different tasks
including MWM, Novel Object Recognition (NOR) and Y-maze
tests at 3, 6 and 12 months old. Using a larger number of Tg+/−
animals, we were able to detect, in the MWM, a spatial reference
memory deficit early at 3 months of age, which persisted at 6 and
12 months. This deficit cannot be explained by a slower learning
curve, as in contrast to the original report (Leon et al., 2010), we
did not find in Tg+/− rats any impairment in the learning phase
of the MWM test. These discrepancies can be explained both by
the number of animals used and by the gender of the animals uti-
lized (males and females in the first report while males only in our
study).
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FIGURE 9 | Spatial reference memory impairment in hemizygous
transgenic McGill-R-Thy1-APP (Tg+/−). Percentage of time spent in
each quadrant of the Morris water maze and number of annulus
crossings during the probe trial at 3 (A,B), 6 (C,D) and 12 (E,F)
months of age. At the three ages tested, WT groups spent significantly
more time in the quadrant where the platform was previously located
(target quadrant) (A,C,D). By contrast, Tg+/− groups spent similar
amount of time in each one of the four quadrants (A,C,D).
Furthermore, Tg+/− groups crossed the annulus zone significantly less
times than WT groups (except at 6 months of age when a strong
tendency was detected; B,D,F), indicating a spatial reference memory
impairment. Dashed lines indicate the percentage of time spent in each
one of the quadrant predicted by chance (25%). L, left quadrant; T,
target quadrant; R, right quadrant; O, opposite quadrant. The number of
animals tested was as follows: 9 WT and 10 Tg+/− at 3 months, 7
WT and 9 Tg+/− at 6 months, and 11 WT and 11 Tg+/− at 12
months. Values are shown as the mean ± s.e.m. #p ≤ 0.05 vs.
percentage of time spent in target quadrant; ∗p ≤ 0.05.
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Memory tasks sensitive to hippocampal functions such as con-
textual fear conditioning (FC), NORL and Y-maze alternation
have been described in different transgenic mice models of AD
(Corcoran et al., 2002; Dineley et al., 2002; Ohno et al., 2004;
Devi and Ohno, 2012; Mitani et al., 2013; Nagahara et al., 2013).
However, none of these tests were assessed in transgenic rats until
a recent report in which hemizygous transgenic McGill-R-Thy1-
APP (Tg+/−) rats showed reduced auditory Fear Conditioning
(FC) and reduced contextual and cued FC recall (Iulita et al.,
2014). In the same study, Tg+/− rats displayed an impairment in
the Novel Object Recognition and Location (NORL) task (Iulita
et al., 2014). The impairment described in the NORL test was not
reproduced by Tg+/− in the NOR task performed in our study.
This could be due to the differential stringency of the tasks as
five objects were used in the previous report (Iulita et al., 2014).
Although both tests are hippocampal-dependent, the NORL is a
more complex task that includes the spatial component that is
absent in the classic NORT test, and may explain the discrepancy
between results. While in the former test one unfamiliar object
had to be discriminated among a total of five objects during the
novel object recognition phase of the task, we employed a more
classical approach with two dissimilar objects (one unfamiliar and
one familiar) that had to be discriminated during the retention
trial. Discrepancies in results reveal that when the complexity of
the task is increased, recognition memory may be also impaired
in this transgenic rat model.
Spontaneous alternation in the Y-maze test estimates the will-
ingness to explore novel stimuli, or to avoid familiar stimuli,
and is an appropriate paradigm to asses working memory and/or
behavioral disinhibition, signs also manifest in AD. Also, the total
number of arm entries in the Y-maze is a parameter used to
assess sensoriomotor capacities. In this study, we did not find sig-
nificant differences in the total number of arm entries between
Tg+/− and WT rats. However, a significant decline was detected
in the percentage of alternation in Tg+/− rats at 6 and 12 months
old. We could not ascribe this reduced rate in spontaneous alter-
nation to behavioral disinhibition since performance of Tg+/−
rats in locomotor and exploratory parameters in the EPM and
OF did not differ from WT. Therefore, it is likely that reduced
spontaneous alternation reflects spatial working memory impair-
ment. Poor performance in Y-maze appears in young mice of
several single transgenic AD models at 2–4 months, when there
are no plaque-like deposits, but these mice have had high levels
of soluble Aβ in their nervous systems from early postnatal life
(Lalonde et al., 2012). These observations are in agreements with
our results, since Tg+/− rats lack parenchymal Aβ plaques but
thus accumulate soluble oligomers intraneuronally.
CONCLUDING REMARKS
In conclusion, in the present time-course study, we investigated
emotional and cognitive symptoms in Tg+/− rats. The most
relevant result is that transgenic rats showed, from adulthood
(6-month-old) to middle age (12-month-old), increased anxi-
ety levels and working memory impairment. Moreover, as early
as 3 months of age, transgenic rats showed an impaired spatial
reference memory in comparison to WT rats. This deficit was
also observed at 6 and 12 months of age. At all ages, recognition
memory and spatial learning were spared. Given that Tg+/− rats
capture many behavioral features of early stages of AD, this new
modelmay represent an important tool for the neuroscience com-
munity to enable future studies in basic and translational AD
research.
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